–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ : Impact Factor & More
eISSN: 2619-1164pISSN: 2312-7821
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ Journal Specifications
| Overview | |
| Publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| Language | Russian |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 12 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Copyright Notice |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏
Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 1
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Title not available
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Preclinical Studies of Modern Radiopharmaceuticals: Expert Approaches to Evaluating the Results
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Safety of Post-Infarction Dual Antiplatelet Therapy and Patient Adherence: EMIAS Data Analysis
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Therapeutic Potential of Myo-Inositol in Male Infertility: Correction of Spermatogenesis Parameters and Oxidative Stress (Review)
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Pharmacogenetic Testing as a Tool to Prevent Isoniazid-Induced Hepatotoxicity in Pulmonary Tuberculosis Therapy: A Case Report
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 1
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Title not available
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Preclinical Studies of Modern Radiopharmaceuticals: Expert Approaches to Evaluating the Results
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Safety of Post-Infarction Dual Antiplatelet Therapy and Patient Adherence: EMIAS Data Analysis
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Therapeutic Potential of Myo-Inositol in Male Infertility: Correction of Spermatogenesis Parameters and Oxidative Stress (Review)
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
Pharmacogenetic Testing as a Tool to Prevent Isoniazid-Induced Hepatotoxicity in Pulmonary Tuberculosis Therapy: A Case Report
- 29 Sep 2025
- Safety and Risk of Pharmacotherapy
FAQs on –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏
How many articles did –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ publish last year? 
What is the eISSN & pISSN for –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏?
Who is the publisher of –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏?
